Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma PatientsHigh-Risk NeuroblastomaRecruitingPhase 2 / Phase 32026-10-08NCT07549321

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Renaissance Pharma Ltd.1

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Charité - Universitätsmedizin BerlinBerlinGermany25
Children's Hospital Colorado Anschutz MedicalAuroraUnited States1
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Duke University Medical CenterDurhamUnited States52
Gustave RoussyVillejuifFrance48
Hospital Sant Joan de DeuBarcelonaSpain11
RigshospitaletCopenhagenDenmark141
Royal Marsden NHS Foundation TrustSuttonUnited Kingdom5
Southampton Children's HospitalSouthamptonUnited Kingdom1
The Children's Hospital at MontefioreThe BronxUnited States9
The Hospital for Sick ChildrenTorontoCanada20
University Hospital Vall d'HebronBarcelonaSpain9
University of California San Francisco (UCSF)San FranciscoUnited States13
University of Minnesota Masonic Children's HospitalMinneapolisUnited States9